AI is changing how we answer the first question on every trial: can this be done, where and how fast?

This is what AI-Augmented feasibility looks like at TFS.

Feasibility sets the trajectory of every trial. Get the country mix wrong, miss a site, underestimate competitive density and a Phase II slips by six months before it has started. The pressure to get it right and get it fast, has always been there. Now the tools to do both exist.

TFS HealthScience has integrated AI into its feasibility methodology not to replace the judgement that makes a recommendation rigorous, but to remove the bottleneck that slows it down.

In this case study you will find:

  • Where AI runs and where experienced feasibility leads take over
  • How 4 in 5 feasibilities in 2026 used this approach to deliver a 35% faster turnaround

The result is a faster path from a sponsor’s first question to a credible answer and a faster trial.

Download the case study to see how it works.

Connect with Us

Contact us today to discover how TFS can be your strategic CRO partner in clinical development.

Let's Talk

Latest resources

 

Sarcoma
Up to 1 in 3 sarcoma diagnoses change on second reviewArticle

Up to 1 in 3 sarcoma diagnoses change on second review

TFS HealthScience on what sponsors should ask before a sarcoma programme begins and how we build protocols around real clinical practice.
The new endpoints reshaping oncology trial designWebinars

The new endpoints reshaping oncology trial design

The endpoint and eligibility shifts reshaping oncology trial design in 2026. Watch the full replay or download the slides.
Co design
Designed with, not for: co-designing clinical trials with patients at the table, not in the waiting roomArticle

Designed with, not for: co-designing clinical trials with patients at the table, not in the waiting room

Most CROs bring patient groups in after the protocol is locked. TFS HealthScience explains why that timing determines whether co-design actually works.